CAMP4 Therapeutics Corporation (CAMP) Financials

CAMP Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 105.5 million 74.6 million
Dec. 31, 2025 117.8 million 70.1 million
Sept. 30, 2025 86.4 million 27.7 million
June 30, 2025 51.3 million 11.3 million

CAMP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -11.0 million 1.5 million
Dec. 31, 2025 6.3 million 1.2 million
Sept. 30, 2025 -11.2 million 984000
June 30, 2025 -10.3 million 1.0 million

CAMP Net Income

No data available :(

CAMP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 99.2 million 1.7 million -
Dec. 31, 2025 109.5 million - 1.7 million
Sept. 30, 2025 75.3 million 3.0 million 6.3 million
June 30, 2025 39.1 million - 7.1 million

CAMP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 57.9 million
Dec. 31, 2025 51.9 million
Sept. 30, 2025 20.2 million
June 30, 2025 20.2 million

CAMP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 9.6 million 4.2 million -
Dec. 31, 2025 - 8.4 million 4.8 million -
Sept. 30, 2025 - 9.4 million 4.6 million -
June 30, 2025 - 10.3 million 4.2 million -

CAMP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.3 million 520000
Dec. 31, 2025 348000 372000
Sept. 30, 2025 795000 416000
June 30, 2025 1.5 million -

CAMP Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CAMP

Price: $4.13

52 week price:
1.31
7.75

Earnings Per Share: -2.35 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 144300

Ebitda: 23.8 million

Market Capitalization: 87.3 million

Links: